DK1636228T3 - Nye pyridopyraziner og deres anvendelse som kinasemodulatorer - Google Patents

Nye pyridopyraziner og deres anvendelse som kinasemodulatorer

Info

Publication number
DK1636228T3
DK1636228T3 DK04733768T DK04733768T DK1636228T3 DK 1636228 T3 DK1636228 T3 DK 1636228T3 DK 04733768 T DK04733768 T DK 04733768T DK 04733768 T DK04733768 T DK 04733768T DK 1636228 T3 DK1636228 T3 DK 1636228T3
Authority
DK
Denmark
Prior art keywords
kinase modulators
pyridopyrazines
novel
novel pyridopyrazines
modulators
Prior art date
Application number
DK04733768T
Other languages
Danish (da)
English (en)
Inventor
Eckhard Guenther
Irene Seipelt
Ulf-R Rapp
Ludmilla Wixler
Eckhard Claus
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10323345A external-priority patent/DE10323345A1/de
Priority claimed from DE102004022383A external-priority patent/DE102004022383A1/de
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1636228T3 publication Critical patent/DK1636228T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04733768T 2003-05-23 2004-05-19 Nye pyridopyraziner og deres anvendelse som kinasemodulatorer DK1636228T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10323345A DE10323345A1 (de) 2003-05-23 2003-05-23 Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
DE102004022383A DE102004022383A1 (de) 2004-05-06 2004-05-06 Neue Pyridopyrazine und deren Verwendung als Modulatoren von Kinasen
PCT/EP2004/005388 WO2004104003A1 (fr) 2003-05-23 2004-05-19 Nouvelles pyridopyrazines et leur utilisation en tant que modulateurs de kinases

Publications (1)

Publication Number Publication Date
DK1636228T3 true DK1636228T3 (da) 2009-02-23

Family

ID=33477517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04733768T DK1636228T3 (da) 2003-05-23 2004-05-19 Nye pyridopyraziner og deres anvendelse som kinasemodulatorer

Country Status (25)

Country Link
US (1) US7276507B2 (fr)
EP (1) EP1636228B1 (fr)
JP (2) JP4571944B2 (fr)
KR (1) KR101111464B1 (fr)
AR (1) AR045686A1 (fr)
AT (1) ATE411992T1 (fr)
AU (1) AU2004240747B2 (fr)
BR (1) BRPI0410633A (fr)
CA (1) CA2524525C (fr)
CY (1) CY1108715T1 (fr)
DE (1) DE502004008322D1 (fr)
DK (1) DK1636228T3 (fr)
ES (1) ES2316985T3 (fr)
HR (1) HRP20090036T3 (fr)
ME (1) ME00541B (fr)
MX (1) MXPA05012645A (fr)
NO (1) NO332005B1 (fr)
NZ (1) NZ544112A (fr)
PL (1) PL1636228T3 (fr)
PT (1) PT1636228E (fr)
RU (1) RU2330851C9 (fr)
SI (1) SI1636228T1 (fr)
TW (1) TWI341839B (fr)
UA (1) UA78929C2 (fr)
WO (1) WO2004104003A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006216998B2 (en) * 2005-02-14 2010-12-23 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
AU2006313701B2 (en) * 2005-11-11 2012-05-31 Aeterna Zentaris Gmbh Novel pyridopyrazines and their use as modulators of kinases
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1785423A1 (fr) * 2005-11-11 2007-05-16 Zentaris GmbH Pyridopyrazines et leur utilisation en tant que modulateurs de kinases
EP1790342A1 (fr) * 2005-11-11 2007-05-30 Zentaris GmbH Dérivés de pyridopyrazine et leur utilisation comme modulateurs de transduction de signal
JO2985B1 (ar) 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk
EP1990342A1 (fr) 2007-05-10 2008-11-12 AEterna Zentaris GmbH Dérivés de pyridopyrazine, processus de fabrication et utilisations correspondantes
KR20120082906A (ko) 2009-09-30 2012-07-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 자가포식현상-향상 유전자 생성물의 조절을 통한 자가포식현상의 조절 방법
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
EP2508184A1 (fr) * 2011-04-06 2012-10-10 Æterna Zentaris GmbH Dérivés de pyridopyrazine et leur utilisation
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
MA39784B1 (fr) 2014-03-26 2021-03-31 Astex Therapeutics Ltd Combinaisons des inhibiteurs du fgfr et du cmet destinées au traitement du cancer
AU2015238305B2 (en) 2014-03-26 2020-06-18 Astex Therapeutics Ltd Combinations of an FGFR inhibitor and an IGF1R inhibitor
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
JO3695B1 (ar) 2015-02-10 2020-08-27 Astex Therapeutics Ltd تركيبات صيدلانية تشتمل على n- (3.5- ثنائي ميثوكسي فينيل)-n-(1-ميثيل إيثيل)-n- 3-( ميثيل-h1-بيرازول-4-يل) كينوكسالين-6-يل) إيثان- 1.2-ثنائي الأمين)
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
KR102703498B1 (ko) 2015-09-23 2024-09-04 얀센 파마슈티카 엔브이 신규 화합물
CN108137546B (zh) 2015-09-23 2021-07-27 詹森药业有限公司 双杂芳基取代的1,4-苯并二氮杂卓化合物及其用于治疗癌症的用途
US11117894B2 (en) 2017-06-22 2021-09-14 City Of Hope Pyridopyrazine compounds and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
TW274550B (fr) * 1992-09-26 1996-04-21 Hoechst Ag
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
UA71555C2 (en) * 1997-10-06 2004-12-15 Zentaris Gmbh Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
WO2003024448A2 (fr) 2001-09-14 2003-03-27 Methylgene, Inc. Inhibiteurs de l'histone-deacetylase
WO2003086394A1 (fr) 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibiteurs de l'activite akt
US20060142178A1 (en) * 2002-04-08 2006-06-29 Barnett Stanley F Method of treating cancer
WO2003086403A1 (fr) 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibiteurs de l'activite de akt
EP1538907A4 (fr) 2002-07-02 2008-12-24 Southern Res Inst Inhibiteurs de ftsz et leurs utilisations
BR0315053A (pt) 2002-10-03 2005-08-09 Targegen Inc Agentes vasculostáticos , composição, artigo e processo de preparação dos mesmos
DE10323345A1 (de) * 2003-05-23 2004-12-16 Zentaris Gmbh Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren

Also Published As

Publication number Publication date
AU2004240747B2 (en) 2008-01-03
MXPA05012645A (es) 2006-02-08
ES2316985T3 (es) 2009-04-16
HRP20090036T3 (en) 2009-03-31
NO20056032L (no) 2006-02-15
NZ544112A (en) 2010-01-29
JP2010209121A (ja) 2010-09-24
HK1090643A1 (zh) 2006-12-29
DE502004008322D1 (de) 2008-12-04
TWI341839B (en) 2011-05-11
SI1636228T1 (sl) 2009-04-30
JP4571944B2 (ja) 2010-10-27
ATE411992T1 (de) 2008-11-15
KR20060038376A (ko) 2006-05-03
ME00541B (fr) 2011-10-10
KR101111464B1 (ko) 2012-02-21
RU2330851C9 (ru) 2008-10-20
TW200505917A (en) 2005-02-16
UA78929C2 (uk) 2007-04-25
CY1108715T1 (el) 2014-04-09
RU2005140377A (ru) 2006-05-10
CA2524525C (fr) 2012-01-03
RU2330851C2 (ru) 2008-08-10
US20040266777A1 (en) 2004-12-30
CA2524525A1 (fr) 2004-12-02
NO332005B1 (no) 2012-05-21
PL1636228T3 (pl) 2009-04-30
EP1636228B1 (fr) 2008-10-22
AU2004240747A1 (en) 2004-12-02
PT1636228E (pt) 2009-02-02
JP5447855B2 (ja) 2014-03-19
WO2004104003A1 (fr) 2004-12-02
JP2006528223A (ja) 2006-12-14
EP1636228A1 (fr) 2006-03-22
US7276507B2 (en) 2007-10-02
BRPI0410633A (pt) 2006-06-13
AR045686A1 (es) 2005-11-09

Similar Documents

Publication Publication Date Title
DK1594867T3 (da) Phenylacetamider og deres anvendelse som glucokinasemodulatorer
DK1499311T3 (da) Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
DK1480955T3 (da) O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
NO20055135D0 (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
DK1723128T3 (da) Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
DK1480962T3 (da) 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer
DK1539712T3 (da) Pyrimidinderivater og deres anvendelse som CB2-modulatorer
DK1789401T3 (da) Isoxazolinderivater og deres anvendelse som herbicider
NO20034187L (no) Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
DK1904475T3 (da) N-thioanthranilamid-forbindelser og deres anvendelse som pesticider
DK1888595T3 (da) Spiro-oxindolforbindelser og deres anvendelser som terapeutiske midler
DK1928879T3 (da) Kondenserede heterocykliske forbindelser og anvendelse heraf som kinase-modulatorer
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1373191T3 (da) Acylerede indanylaminer og deres anvendelse som lægemidler
DK1931645T3 (da) N-(3-aminoquinoxalin-2-yl)-sulfonamidderivater og deres anvendelse som inhibitorer af phosphatidylinositol-3-kinase
NO20030302L (no) Nye heteroarylderivater og deres anvendelse som medikamenter
NO20054083D0 (no) Nye sammenkoblede triazoloner og deres anvendelse
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
ATE456558T1 (de) Gabanerge modulatoren
DK1670458T3 (da) 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
DK1581518T3 (da) Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
DK1799649T3 (da) 3-(2-hydroxyphenyl)-pyrazoler og deres anvendelse som hsp90-modulatorer
PL1636228T3 (pl) Nowe pirydopirazyny i ich zastosowanie jako modulatorów kinazy
DK1723135T3 (da) Kendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer